Stock prices for live music companies skyrocketed Monday morning on news that a COVID-19 vaccine was found to be 90% effective. At 9:15 am ET, just 30 minutes after Pfizer’s press release with its vaccine trial results, Live Nation was +20.8% to $67.73, Madison Square Garden Entertainment was +21.4% to $84.44 and Germany concert promoter CTS Eventim was +23.5% to $51.90.
Source: Live Music Stocks Soar on COVID-19 Vaccine Breakthrough